Posts by: Alice Melão

News

Midbrain atrophy, commonly referred to as the hummingbird or penguin sign, can be a manifestation of fragile X-associated tremor/ataxia syndrome (FXTAS) and can mimic progressive supranuclear palsy, a case report ... Read more

June 18, 2019June 18, 2019

Social Avoidance Behaviors Emerge in Infancy, Increase During Childhood, Study Finds

News

Social avoidance, a common behavior among boys with fragile X syndrome, emerges during infancy, increases in severity across childhood, and stabilizes through adolescence and early adulthood, a study finds. ... Read more

February 19, 2019February 19, 2019

Information, Support May Persuade Parents of FXS Children to Join Trials

News

Parents of children with intellectual disability, in particular those affected by fragile X syndrome, may benefit from more information and dedicated support when considering the possibility of participating in ... Read more

January 22, 2019January 22, 2019

Inhibiting HDAC6 Enzyme Has Potential for Treating FRX, Mouse Study Finds

News

Inhibiting the HDAC6 enzyme with an experimental agent called SW-100 improved memory and lowered learning impairments in a mouse model of fragile X syndrome (FXS), a study has shown. ... Read more

January 3, 2019January 3, 2019

FMR1 Mutations Linked to Early Atypical Temperament, Study Shows

News

Mutations in the FMR1 gene are associated with atypical temperament that can emerge as early as infancy, particularly among infants with fragile X syndrome, a study has shown. The ... Read more

December 18, 2018December 18, 2018

Cannabidiol Gel ZYN002 Shows Sustained Benefits in Children and Teens with Fragile X, Zynerba Reports

News

One year of treatment with the cannabidiol gel ZYN002, being developed by Zynerba Pharmaceuticals, can provide sustained benefit to young patients with fragile X syndrome, data from a Phase 2 ... Read more

September 27, 2018September 27, 2018

Cellular ‘Cleaning System’ a Possible Therapeutic Target for Fragile X, Mouse Study Finds

News

Autophagy, a natural process that acts as a “cleaning system” for cells, plays an important role in regulating the activity of brain cells and cognitive deficits associated with fragile ... Read more

September 20, 2018September 20, 2018

Human iPSCs Beneficial for Study of Autism Spectrum Disorders, but Limitations Still Exist, Review Says

News

Human induced pluripotent stem cells, also known as iPSCs, are valuable tools for discovering new targets and treatment strategies for several diseases, including autism spectrum disorders, despite some limitations ... Read more

July 31, 2018July 31, 2018

Ovid Starts Phase 2 ROCKET Trial Testing OV101 in Adolescents with Fragile X Syndrome

News

Ovid Therapeutics has initiated the Phase 2 ROCKET clinical trial to assess the safety, tolerability, and efficacy of OV101 (gaboxadol) as a treatment for adolescents and young adults with ... Read more

May 8, 2018May 8, 2018

Fragile X Syndrome Linked to Impaired Brain White Matter Development, Researchers Say

News

Babies with fragile X syndrome have less-developed brain white matter compared to those without the syndrome, according to researchers. Their study, “Development of White Matter Circuitry in Infants With ... Read more

Posts by: Alice Melão

Alice Melão

Report: Hummingbird Sign Links FXTAS, Progressive Supranuclear Palsy

Information, Support May Persuade Parents of FXS Children to Join Trials

Inhibiting HDAC6 Enzyme Has Potential for Treating FRX, Mouse Study Finds

FMR1 Mutations Linked to Early Atypical Temperament, Study Shows

Cannabidiol Gel ZYN002 Shows Sustained Benefits in Children and Teens with Fragile X, Zynerba Reports

Cellular ‘Cleaning System’ a Possible Therapeutic Target for Fragile X, Mouse Study Finds

Human iPSCs Beneficial for Study of Autism Spectrum Disorders, but Limitations Still Exist, Review Says

Ovid Starts Phase 2 ROCKET Trial Testing OV101 in Adolescents with Fragile X Syndrome

Fragile X Syndrome Linked to Impaired Brain White Matter Development, Researchers Say

Pin It on Pinterest